May 13, 2020 / 08:20PM GMT
Geoffrey Christopher Meacham - BofA Merrill Lynch, Research Division - Research Analyst
Okay. Welcome to the afternoon sessions of the second day of the BofA Virtual Vegas Health Care Conference. I'm Geoff Meacham, I'm the senior biopharma analyst here at BofA. I have also Jason Zemansky from my team on as well. And we're really excited to have United Therapeutics present today with slides. And speaking on behalf of United, we have James Edgemond, the CFO. James, are you there?
James C. Edgemond - United Therapeutics Corporation - CFO & Treasurer
I am, Geoff. Thank you for the introduction. I'd like to thank you, yes. And I'd like to thank you and Jason and BofA Securities for the opportunity to present United Therapeutics at your Virtual Health Care Conference this afternoon. Good afternoon, everyone, and thank you for listening to our webcast presentation. I'm joined today on this webcast by my colleague, Mr. Dewey Steadman, United Therapeutics Head of Investor Relations. We've organized our presentation today into 3 sections, which consists of an overview
United Therapeutics Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers